Saturday, December 06, 2025 | 02:36 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

The real pandemic risk from India is tracking new variants of Covid-19

As countries help India, they should ask for greater genomic scrutiny of the emerging strains of the virus.

Coronavirus, covid, tests
premium

A health worker takes swab sample from a man for Covid-19 test, in Jammu

Andy Mukherjee | Bloomberg Opinion
If you haven’t heard of B.1.617 yet, chances are you soon will.

This particular Covid-19 variant is at least partly behind the overwhelming second wave in India, the current global epicenter of the pandemic. The World Health Organization has now raised B.1.617 from a “variant of interest” to a “variant of concern.” Authorities like Public Health England are already treating it as the latter, meaning there’s something worrying about one or more of the criteria on which a virus is judged--including how fast it transmits, how many it kills, and whether it evades detection or makes vaccines less effective.  

The stakes underlying